134 related articles for article (PubMed ID: 38715706)
1. Corrigendum: MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer.
Thomopoulou K; Papadaki C; Monastirioti A; Koronakis G; Mala A; Kalapanida D; Mavroudis D; Agelaki S
Front Mol Biosci; 2024; 11():1413164. PubMed ID: 38715706
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs Regulating Tumor Immune Response in the Prediction of the Outcome in Patients With Breast Cancer.
Thomopoulou K; Papadaki C; Monastirioti A; Koronakis G; Mala A; Kalapanida D; Mavroudis D; Agelaki S
Front Mol Biosci; 2021; 8():668534. PubMed ID: 34179081
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis.
Zhang X; He X; Li Y; Xu Y; Chen W; Liu X; Hu X; Xiong L; Xu X
Front Mol Biosci; 2021; 8():826905. PubMed ID: 35004862
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Evaluation of
Peixoto A; Cirnes L; Carvalho AL; Andrade MJ; Maria José Brito ; Borralho P; Coimbra N; Borralho PM; Carneiro AS; Castro L; Correia L; Dionísio MR; Faria C; Figueiredo P; Gomes A; Paixão J; Pinheiro M; Prazeres H; Ribeiro J; Salgueiro N; Schmitt FC; Silva F; Silvestre AR; Sousa AC; Almeida-Tavares J; Teixeira MR; André S; Machado JC
Front Mol Biosci; 2024; 11():1298522. PubMed ID: 38721275
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Comprehensive analysis of the potential immune-related biomarker transporter associated with antigen processing 1 that inhibits metastasis and invasion of ovarian cancer cells.
Li X; Zeng S; Ding Y; Nie Y; Yang M
Front Mol Biosci; 2022; 9():984209. PubMed ID: 36120547
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ
Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer.
Zheng Y; Zhong G; Yu K; Lei K; Yang Q
Front Oncol; 2020; 10():482. PubMed ID: 32328463
[TBL] [Abstract][Full Text] [Related]
8. Erratum: A DNA Methylation-Based Panel for the Prognosis and Diagnosis of Patients With Breast Cancer and Its Mechanisms.
Frontiers Production Office
Front Mol Biosci; 2020; 7():596445. PubMed ID: 33282913
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer.
Wang Z; Jia L; Yushu Sun ; Li C; Zhang L; Wang X; Chen H
Front Mol Biosci; 2021; 8():727347. PubMed ID: 34527704
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Immune Response in Myocardial Injury:
Chong PY; Iqbal J; Yeong J; Aw TC; Chan KS; Chui P
Front Mol Biosci; 2022; 9():887178. PubMed ID: 35433836
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy.
Thomas RG; Surendran SP; Jeong YY
Front Mol Biosci; 2021; 8():693909. PubMed ID: 34026853
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer.
Papadaki C; Thomopoulou K; Monastirioti A; Koronakis G; Papadaki MA; Rounis K; Vamvakas L; Nikolaou C; Mavroudis D; Agelaki S
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33924670
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Sestrin2 protects against hypoxic nerve injury by regulating mitophagy through SESN2/AMPK pathway.
Pan C; Ai C; Liang L; Zhang B; Li Q; Pu L; Wang Z; Liu W; Chen Z; Liu H; Wang X
Front Mol Biosci; 2024; 11():1392150. PubMed ID: 38645273
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer.
Frontiers Production Office
Front Mol Biosci; 2022; 9():1094902. PubMed ID: 36533079
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: The Immune System in Transfusion-Related Acute Lung Injury Prevention and Therapy: Update and Perspective.
Guo K; Ma S
Front Mol Biosci; 2021; 8():720653. PubMed ID: 34513926
[TBL] [Abstract][Full Text] [Related]
16. Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics.
Fortis SP; Vaxevanis CK; Mahaira LG; Sofopoulos M; Sotiriadou NN; Dinou A; Arnogiannaki N; Stavropoulos-Giokas C; Thanos D; Baxevanis CN; Perez SA
Cancer Immunol Immunother; 2019 Jan; 68(1):57-70. PubMed ID: 30276443
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: 6-Shogaol inhibits oxidative stress-induced rat vascular smooth muscle cell apoptosis by regulating OXR1-p53 axis.
Liu J; Li B; Li W; Pan T; Diao Y; Wang F
Front Mol Biosci; 2023; 10():1308875. PubMed ID: 37916191
[TBL] [Abstract][Full Text] [Related]
18. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Identification of a Potential miRNA-mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF.
Ma S; Xie Z; Zhang L; Yang Y; Jiang H; Ouyang X; Zhao Y; Liu Q; Xu X; Li L
Front Mol Biosci; 2021; 8():705683. PubMed ID: 34268336
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer.
Fischer C; Deutsch TM; Feisst M; Rippinger N; Riedel F; Hartkopf AD; Brucker SY; Domschke C; Fremd C; Michel L; Burwinkel B; Schneeweiss A; Turchinovich A; Wallwiener M
Arch Gynecol Obstet; 2022 Sep; 306(3):875-885. PubMed ID: 35237856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]